Group One Trading
CBIO

Group One Trading’s Crescent Biopharma CBIO Stock Holding History

Group One Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$50 – 7873
2024
Q4 		$50 Hold
2
– – ﹤0.01% 7125
2024
Q3 		$34 Buy
+2
New +$42 ﹤0.01% 6508
2024
Q2 		– Sell
-10
Closed -$3K – 7003
2024
Q1 		$3K Hold
10
– – ﹤0.01% 6381
2023
Q4 		$2.36K Buy
+10
New +$1.55K ﹤0.01% 6775
2023
Q3 		– Sell
-158
Closed -$27.5K – 7871
2023
Q2 		$27.5K Buy
158
+10
+7% +$1.68K ﹤0.01% 5751
2023
Q1 		$18.6K Buy
+148
New +$33.3K ﹤0.01% 5559
2022
Q1 		– Sell
-368
Closed -$53K – 8256
2021
Q4 		$53K Sell
368
-276
-43% -$50.1K ﹤0.01% 6285
2021
Q3 		$141K Buy
644
+333
+107% +$70.5K ﹤0.01% 5540
2021
Q2 		$72K Buy
311
+144
+86% +$36.6K ﹤0.01% 6256
2021
Q1 		$50K Sell
167
-2
-1% -$716 ﹤0.01% 6224
2020
Q4 		$64K Sell
169
-15
-8% -$5.26K ﹤0.01% 4855
2020
Q3 		$56K Buy
184
+20
+12% +$7.64K ﹤0.01% 4571
2020
Q2 		$62K Buy
164
+104
+173% +$29.4K ﹤0.01% 4221
2020
Q1 		$14K Sell
60
-14
-19% -$5.35K ﹤0.01% 4418
2019
Q4 		$39K Hold
74
– – ﹤0.01% 4117
2019
Q3 		$32K Buy
+74
New +$47.6K ﹤0.01% 4183
2018
Q1 		– Sell
-224
Closed -$376K – 5006
2017
Q4 		$376K Buy
+224
New +$296K ﹤0.01% 2484

Other funds holding CBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's CBIO Position: Q1 2026 in Review

Group One Trading sold out of Crescent Biopharma (CBIO) in Q1 2026, closing a stake of 4 shares — an estimated $47 sold.

Group One Trading first reported a position in CBIO in Q4 2017 and held it in 20 quarters. The position peaked at $136K in Q3 2020. 63 funds tracked by Wall St. Rank hold CBIO as of Q1 2026.

  • Group One Trading reported no remaining Crescent Biopharma position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 4 Crescent Biopharma shares in Q1 2026, an estimated $47.
  • Group One Trading first reported a position in Crescent Biopharma in Q4 2017 and held it in 20 quarters.
  • Group One Trading's Crescent Biopharma position peaked at $136K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Crescent Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.